Home>>Peptides>>[Sar1, Ile8]-Angiotensin II TFA

[Sar1, Ile8]-Angiotensin II TFA (Synonyms: AngiotensinII TFA; Angiotensin 2 TFA)

Catalog No.GC35026

[Sar1, Ile8]-Angiotensin II (TFA) is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels.

Products are for research use only. Not for human use. We do not sell to patients.

[Sar1, Ile8]-Angiotensin II TFA Chemical Structure

Size Price Stock Qty
10mM (in 1mL DMSO)
$122.00
In stock
10mg
$102.00
In stock
50mg
$389.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Video Related Products

[Sar1, Ile8]-Angiotensin II (TFA) is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels.

[Sar1, Ile8]-Angiotensin II (TFA) has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels. [Sar1, Ile8]-Angiotensin II (TFA) activates both the NADPH and NADH oxidases, and stimulates superoxide anion formation in vascular smooth muscle cells[1].

[1]. Griendling KK, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994 Jun;74(6):1141-8.

Reviews

Review for [Sar1, Ile8]-Angiotensin II TFA

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for [Sar1, Ile8]-Angiotensin II TFA

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.